Table of Contents
< Prev Issue | Next Issue >

Volume 3 Issue 2, Jun 2018

Article
Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models
Nicholas L. Syn,Pei Li Lim,Li Ren Kong,Lingzhi Wang,Andrea Li-Ann Wong,Chwee Ming Lim,Thomas Kwok Seng Loh,Gerhard Siemeister,Boon Cher Goh &…Wen-Son Hsieh 
https://doi.org/10.1038/s41392-018-0010-0
Full Text | PDF | Abstract
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
Masayuki Hiraki,Takahiro Maeda,Neha Mehrotra,Caining Jin,Maroof Alam,Audrey Bouillez,Tsuyoshi Hata,Ashujit Tagde,Amy Keating,Surender Kharbanda,Harpal Singh &…Donald Kufe  ORCID: orcid.org/0000-0001-5743-8888 
https://doi.org/10.1038/s41392-018-0013-x
Full Text | PDF | Abstract
Review Article
Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival
Enrique Rozengurt,James Sinnett-Smith &Guido Eibl  ORCID: orcid.org/0000-0003-3497-4527 
https://doi.org/10.1038/s41392-017-0005-2
Full Text | PDF | Abstract
miRNAs reshape immunity and inflammatory responses in bacterial infection
Xikun Zhou,Xuefeng Li &Min Wu  ORCID: orcid.org/0000-0003-1205-982X 
https://doi.org/10.1038/s41392-018-0006-9
Full Text | PDF | Abstract
Brief Communication
Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapy
Kentaro Miyake  ORCID: orcid.org/0000-0002-4680-4317,Tasuku Kiyuna,Masuyo Miyake,Kei Kawaguchi,Sang Nam Yoon,Zhiying Zhang,Kentaro Igarashi,Sahar Razmjooei,Sintawat Wangsiricharoen,Takashi Murakami,Yunfeng Li,Scott D. Nelson,Tara A. Russell,Arun S. Singh,Yukihiko Hiroshima,Masashi Momiyama,Ryusei Matsuyama,Takashi Chishima,Shree Ram Singh  ORCID: orcid.org/0000-0001-6545-583X,Itaru Endo,Fritz C. Eilber &…Robert M. Hoffman 
https://doi.org/10.1038/s41392-018-0016-7
Full Text | PDF | Abstract